BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21254093)

  • 1. Impaired respiratory function in mdx and mdx/utrn(+/-) mice.
    Huang P; Cheng G; Lu H; Aronica M; Ransohoff RM; Zhou L
    Muscle Nerve; 2011 Feb; 43(2):263-7. PubMed ID: 21254093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.
    Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM
    J Neurol Sci; 2008 Jan; 264(1-2):106-11. PubMed ID: 17889902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness.
    Burns DP; Murphy KH; Lucking EF; O'Halloran KD
    J Physiol; 2019 Feb; 597(3):831-848. PubMed ID: 30570134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
    van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
    Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice.
    Markham BE; Kernodle S; Nemzek J; Wilkinson JE; Sigler R
    PLoS One; 2015; 10(8):e0134832. PubMed ID: 26248188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mdx respiratory impairment following fibrosis of the diaphragm.
    Ishizaki M; Suga T; Kimura E; Shiota T; Kawano R; Uchida Y; Uchino K; Yamashita S; Maeda Y; Uchino M
    Neuromuscul Disord; 2008 Apr; 18(4):342-8. PubMed ID: 18358722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
    Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
    J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
    Berry SE; Liu J; Chaney EJ; Kaufman SJ
    Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
    Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
    Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
    Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
    Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of compensation afforded by accessory muscles of breathing leads to respiratory system compromise in the mdx mouse model of Duchenne muscular dystrophy.
    O'Halloran KD; Maxwell MN; Marullo AL; Hamilton CP; Ó Murchú SC; Burns DP; Mahony CM; Slyne AD; Drummond SE
    J Physiol; 2023 Oct; 601(19):4441-4467. PubMed ID: 37688347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory Control in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Burns DP; Edge D; O'Malley D; O'Halloran KD
    Adv Exp Med Biol; 2015; 860():239-44. PubMed ID: 26303487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
    Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
    Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy.
    Sahani R; Wallace CH; Jones BK; Blemker SS
    J Appl Physiol (1985); 2022 Mar; 132(3):653-672. PubMed ID: 35050792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of respiratory function in mdx mice co-treated with neutralizing interleukin-6 receptor antibodies and urocortin-2.
    Burns DP; Canavan L; Rowland J; O'Flaherty R; Brannock M; Drummond SE; O'Malley D; Edge D; O'Halloran KD
    J Physiol; 2018 Nov; 596(21):5175-5197. PubMed ID: 30160301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.